{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-104899","form_type":"8-K","ticker":"IPSC","cik":"0001850119","company_name":"Century Therapeutics, Inc.","filed_at":"2022-10-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.735472+00:00","generated_at":"2026-06-23T06:06:49.688548+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Century Therapeutics adds Quimi and Walbert to board after Casdin resigns","bullets":["Eli Casdin resigned as Class I director effective Oct 1, 2022, not due to any disagreement with the Company.","Board expanded to 8 seats; appointed Daphne Quimi (CFO of Amicus Therapeutics) as Class I director.","Appointed Timothy P. Walbert (CEO of Horizon Therapeutics) as Class II director.","Quimi joins Audit and Nominating/Governance committees; Walbert joins Compensation Committee.","Each received a non-qualified option for 39,744 shares at $9.89, vesting over 36 months."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-104899","json":"https://secwatch.observer/filing/0001104659-22-104899.json","markdown":"https://secwatch.observer/filing/0001104659-22-104899.md","text":"https://secwatch.observer/filing/0001104659-22-104899.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1850119/000110465922104899/0001104659-22-104899-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1850119/000110465922104899/tm2227161d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T06:06:49.688548+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"41b7465119","claim":"Eli Casdin resigned as Director at Century Therapeutics, Inc..","evidence_excerpt":"Eli Casdin tendered his resignation as a member of the board of directors (the “ Board ”) of Century Therapeutics, Inc.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1850119/000110465922104899/0001104659-22-104899-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"c490617fdd","claim":"Timothy P. Walbert was appointed as Director at Century Therapeutics, Inc..","evidence_excerpt":"and (ii) Mr. Timothy P. Walbert to serve as a Class II director","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1850119/000110465922104899/0001104659-22-104899-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"e50290da5c","claim":"Daphne Quimi was appointed as Director at Century Therapeutics, Inc..","evidence_excerpt":"the Board appointed (i) Ms. Daphne Quimi to serve as a Class I director of the Company","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1850119/000110465922104899/0001104659-22-104899-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}